Zynerba Pharmaceuticals, Inc.

Ownership Transactions Reported by 12 Insiders

Industry
Pharmaceutical Preparations
Location
80 W. Lancaster Avenue, Suite 300, Devon, PA

There are no Buy or Sell transactions made by insiders since 9/17/2023

Zynerba Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
William J. Federici Director Oct 10, 2023
Kenneth I. Moch Director Oct 10, 2023
Brian Rosenberger VP, Commercial & Business Dev. Oct 10, 2023
Albert P. Parker Chief Legal Officer Oct 10, 2023
Kenneth T. Jones Vice President, Corporate Controller and Interim Chief Financial Officer Oct 10, 2023
Daniel L. Kisner Director Oct 10, 2023
Armando Anido Chairman & Chief Exec. Officer, Director Oct 10, 2023
Terri B. Sebree President Oct 10, 2023
James E. Fickenscher Chief Financial Officer Oct 10, 2023
John P. Butler Director Oct 10, 2023
Warren D. Cooper Director Oct 10, 2023
Pamela Stephenson Director Oct 10, 2023

Recent Insider Transactions by Companies or Individuals for Zynerba Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.